AJMC: Center on Health Equity & Access

Scott Shannon, MD, MAPP1/2 study investigator, expressed disappointment and concern over the FDA’s refusal to approve the use of midomafetamine capsules as part of treatment for adults living with posttraumatic stress disorder. Read the article to learn more: https://lnkd.in/eri5xfsh #MDMA #PTSD

Breaking News: Expanding Medicare coverage for semaglutide could make millions of older Americans newly eligible for the drug, but with the potential to add up to $145 billion annually to federal health care costs; the decision hinges on how broadly "cardiovascular disease" is defined. https://lnkd.in/e8qdUKKN #GLP1 #CMS #Medicare #Cardio

Now that Lykos Therapeutics' application for midomafetamine capsules in combination with assisted psychotherapy for PTSD was rejected by the FDA, what happens now? AJMC - The American Journal of Managed Care gathered the perspectives of 5 experts from different aspects of psychedelic medicine and Veteran Health. *Access to this exclusive article is free! All you have to do is sign in to read more. https://lnkd.in/dX5PWrkZ #PTSD #MDMA #FDA Giuliana Grossi

Following the FDA's rejection of midomafetamine (#MDMA) capsules in combination with assisted therapy for adults with PTSD, Lykos Therapeutics announces a 75% workforce reduction and a plan for reorganization focusing on clinical development and FDA engagement to continue its commitment to progressing the psychedelic therapy forward. https://lnkd.in/etJ9VCtG #PTSD #FDA

A report published today by The Commonwealth Fund reveals the dire state of women's health care. "As of 2022, women in the US had the lowest life expectancy of 80 years compared with women in other high-income countries, with the highest rate of avoidable deaths (270 per 100,000) as of 2021." https://lnkd.in/d7JJJ_qp Giuliana Grossi #healthaccess #UShealth #HealthSystem

"While resources and strategies to combat social determinants of health do exist, effectively leveraging them requires a coordinated approach involving supportive policies, technical assistance, community governance, and sustainable financing." Jayme Ambrose, DNP, CEO of Adobe Population Health Read more: https://lnkd.in/ew6f79vm #SDOH #healthequity #healthcare

“We are incredibly disappointed that the FDA made the wrong decision in the face of such an urgent need and clear demand from the veteran community and others suffering from PTSD," Brett Waters, attorney, cofounder and executive director of Reason for Hope, tells AJMC. "Delay is only going to lead to more unnecessary suffering and lives lost... We're going to continue working tirelessly to help get this over the finish line, because there are far too many people who are going to continue suffering, and unfortunately, too many lives that are going to be lost in the interim.” https://lnkd.in/e25-utMH #MDMA #FDA #MentalHealth

BREAKING “I'm deeply disturbed by the FDA’s unwillingness to look at the data carefully and to have people who are equipped to assess the science make this decision and recommendation,” MAPP1/2 study investigator Scott Shannon, MD, tells AJMC. “I would urge the FDA to create a new division of psychedelic medicine so that we don't lose out on this important avenue of research which has the potential to transform mental health care at a time when we’re deeply mired in crisis and ineffective treatments.” https://lnkd.in/e25-utMH #MDMA #FDA #PTSD #VeteranHealth

Musarrat Perveen of Coordination of Action Research on AIDS and Mobility, delves into how migrant workers have historically been excluded from programs and policies that consider the health care–related implications of HIV/AIDS, why these individuals face a higher risk of HIV, and their self-reported top health care priorities and primary challenges to equitable care access. https://lnkd.in/ebcySV_4 #healthcare #healthequity

With the FDA decision on MDMA-assisted therapy for individuals with PTSD expected later this week, Jack Bergman and 60 other members of Congress hailed MDMA-assisted therapy as a promising solution in addressing the suicide epidemic among veterans. https://lnkd.in/efxV2HSs #HealthAccess #MDMA #VeteranHealth